Cytokines Induce Uridine Phosphorylase in Mouse Colon 26 Carcinoma Cells and Make the Cells More Susceptible to 5′‐Deoxy‐5‐fluorouridine
- 1 March 1993
- journal article
- research article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 84 (3) , 341-347
- https://doi.org/10.1111/j.1349-7006.1993.tb02876.x
Abstract
The antiproliferative activity of 5‐fluorouracil (5‐FUra) and 5′‐deoxy‐5‐fluorouridine (5′‐dFUrd), used in combination with typical cytokines and growth factors, was investigated in mouse colon 26 carcinoma cells. Tumor necrosis factor α (TNFα), interleukin‐1a (IL‐1α), and interferon γ (IFNγ) at low doses showing < 50% inhibition of cell growth by themselves enhanced the susceptibility of the cells to the activity of 5′‐dFUrd. In particular, a mixture of these cytokines greatly enhanced the activity of 5′‐dFUrd and 5‐FUra by up to 12.4‐ and 2.7‐fold, respectively, whereas the activity of other cytostatics was only slightly changed (< 1.5‐fold). Basic fibroblast growth factor also increased the susceptibility, but only to 5′‐dFUrd. This preferential enhancement of the activity of 5′‐dFUrd would be due to induction by the cytokines of uridine phosphorylase (Urd Pase), by which 5′‐dFUrd is converted to 5‐FUra. TNFα, IL‐1α, IFNγ, and a mixture of these factors increased the enzyme activity by up to 3.7‐fold in colon 26 cells. Consequently, the anabolism of 5′‐dFUrd to fluoronucleotides and the incorporation of 5‐FUra into RNA in colon 26 cells were increased by TNFα treatment. In addition, the increase by the cytokine mixture in the susceptibility to 5′‐dFUrd was abolished by an inhibitor of Urd Pase, 2,2′‐anhydro‐5‐ethyluridine. These results indicate that induction of Urd Pase activity by cytokines is a critical event that increases the susceptibility to 5′‐dFUrd.Keywords
This publication has 35 references indexed in Scilit:
- Platelet-derived endothelial cell growth factor has thymidine phosphorylase activityBiochemical and Biophysical Research Communications, 1992
- Interactions of interferon-α2a with 5′-deoxy-5-fluorouridine in colorectal cancer cells in vitroEuropean Journal Of Cancer, 1992
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1992
- Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell linesInternational Journal of Cancer, 1990
- The efficacy of combined treatment with recombinant human tumor necrosis factor-α and 5-fluorouracil is dependent on the development of capillaries in tumorEuropean Journal of Cancer and Clinical Oncology, 1990
- Interferon effects upon fluorouracil metabolism by HL-60 cellsBiochemical and Biophysical Research Communications, 1989
- Anti‐tumor effects of tumor necrosis factor in combination with chemotherapeutic agentsInternational Journal of Cancer, 1987
- Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridinePublished by Elsevier ,1980